Skip to main content

Table 1 Frequencies of DNA methylation in the cancer tissue samples

From: Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis

Loci ID Samples availablea Methylation-negative, n(%) Low methylation, n(%)b Heterogeneous methylation, n(%) Full methylation, n(%) Both alleles present, n(%)
TITF1 220 0 (0.0) 38 (17.3) 0 145 (65.9) 37 (16.8)
HOXB13 239 18 (7.5) 20 (8.4) 0 23 (9.6) 178 (74.5)
NR2E1 164 15 (9.1) 14 (8.5) 18 (11.0) 89 (54.3) 28 (17.1)
HTR1B 162 28 (17.3) 68 (42.0) 20 (12.3) 4 (2.5) 42 (25.9)
HMX2 187 9 (4.8) 1 (0.5) 13 (7.0) 164 (87.7) 0
BC008699 261 4 (1.5) 4 (1.5) 26 (10.0) 206 (78.9) 21 (8.0)
SLC38A4 234 0 16 (6.8) 93 (39.7) 80 (34.2) 45 (19.2)
FLJ32447 264 0 28 (10.6) 191 (72.3) 48 (18.2) 0
WT1 218 44 (20.2) 0 178 (81.7) 21 (9.6) 0
TMEM132D 218 6 (2.8) 21 (9.6) 154 (70.6) 16 (7.3) 21 (9.6)
NKX2-3 169 0 16 (9.5) 108 (63.9) 38 (22.5) 7 (4.1)
GHSR 260 56 (21.5) 24 (9.2) 180 (69.2) 0 0
ONECUT 243 0 16 (9.5) 134 (55.1) 63 (25.9) 30 (12.3)
LHX1 243 0 28 (11.5) 145 (59.7) 41 (16.9) 29 (11.9)
SIX6 246 5 (2.0) 11 (4.5) 173 (70.3) 55 (22.4) 2 (0.8)
CA10 230 21 (9.1) 48 (20.9) 137 (59.6) 24 (10.4) 0
CHR 252 0 44 (17.5) 192 (76.2) 16 (6.3) 0
POU4F 255 10 (3.9) 6 (2.4) 195 (76.5) 44 (17.3) 0
PHOX2B 256 0 3 (1.2) 199 (77.7) 53 (20.7) 1 (0.4)
  1. aVariable numbers of the samples are reported because of clinical sample limitations. bLow methylation is referred to as methylation similar to the methylation observed in control samples.